[Objective criteria of phlebosclerosation].
D001555:Benzene Derivatives / Q000627:therapeutic use; D001794:Blood Pressure; D005260:Female; D006801:Humans; D007455:Iodine / Q000627:therapeutic use; D008297:Male; D008365:Manometry; D008875:Middle Aged; D011187:Posture; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D012964:Sodium / Q000627:therapeutic use; D013997:Time Factors; D014648:Varicose Veins / Q000188:drug therapy* / Q000503:physiopathology
D001555:Benzene Derivatives; D012597:Sclerosing Solutions; D007455:Iodine; D012964:Sodium
Objektivierung der Sklerosierungstherapie durch periphere Phlebodynamometrie.